GlassScriptPhysician profile
Rafael Yanes
NPI 1326272873
$8,842.50
in general payments reported to CMS, 2019-2025
56 companies · $538 in 2025
The $538 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,944 · 2020: $823 · 2021: $1,234 · 2022: $1,216 · 2023: $2,466 · 2024: $622 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,411 · Travel and Lodging: $1,117 · Education: $97.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,411.08 |
| Travel and Lodging | $1,116.76 |
| Education | $97.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,907.83 | 2019-2025 | Lithovue, Watchman Flx |
| Olympus Corporation of The Americas | $801.80 | 2019 | |
| 180 Medical, INC. | $648.82 | 2020-2024 | Gentlecath |
| Teleflex LLC | $266.20 | 2021-2022 | |
| Astellas Pharma US INC | $232.74 | 2019-2024 | Myrbetriq |
| Endo Pharmaceuticals INC. | $207.07 | 2019-2020 | |
| Photocure INC | $198.21 | 2023 | Cysview |
| Neotract INC. | $192.01 | 2019 | |
| Urovant Sciences INC | $187.57 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $177.62 | 2021-2023 | Prolaris |
| Sumitomo Pharma America, INC. | $177.41 | 2023-2025 | Gemtesa, Orgovyx |
| Olympus America INC. | $169.57 | 2019-2023 | Itind System |
| Exact Sciences Corporation | $162.01 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axonics, INC. | $160.98 | 2020-2022 | |
| Abbvie INC. | $143.20 | 2020-2023 | Lupron Depot, Botox |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Yanes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.